Author: SERB Pharmaceuticals

Posted Date:

May 19, 2026

SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million

SERB Pharmaceuticals

May 19, 2026
SERB Pharmaceuticals Announces ThyroSafe 130 mg Potassium Iodide Tablets are Now Commercially Available in the US

SERB Pharmaceuticals

May 7, 2026